Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

QiC Oncology

- PMLiVE

FDA says Janssen’s myeloma drug is a ‘breakthrough therapy’

Should speed up regulatory process for daratumumab

- PMLiVE

Pharma industry must listen to pharmacies

Closer relationship necessary to improve medicines optimisation says senior public health adviser

- PMLiVE

Two new cancer drugs recommended in Europe

CHMP backing for Roche's Erivedge and Astellas' Xtandi

ABPI London offices

ABPI: Pharma must sell outcomes, not products

Annual conference told industry must re-establish its social contract with the NHS

- PMLiVE

AstraZeneca supports NHS medication passport app

Backs NIHR-NHS initiative under joint working agreement

- PMLiVE

AstraZeneca signs $200m deal with Bind for cancer drug

Follows deals with Amgen and Pfizer for Bind involving its Accurin nanotechnology

- PMLiVE

Roche faces another NICE rejection for Avastin

Draft guidance turns down drug for use in ovarian cancer

- PMLiVE

Revamping the NHS and the challenges for pharma

As changes reshape England’s National Health Service, how should pharma engage with the new CCGs?

- PMLiVE

US-based Millennium launches blood cancer website

The Takeda Oncology Company roll out new multiple myeloma website

- PMLiVE

Pharmaceutical conference to discuss healthcare in the new NHS

ABPI’s chief executive calls for “bold, provocative ideas” in new UK healthcare landscape

ABPI London offices

Pharma paid UK healthcare professionals £40m in 2012

Payments published as part of ABPI drive towards greater industry transparency

- PMLiVE

Roche launches test for thyroid cancer

Elecsys Calcitonin to support diagnosis of relapse following surgery

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links